Jacobs Bruce N.
Chief Financial Officer
CIK: 1821074
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 6,153 | $116.99 | $719,862.24 | View Details Filing |
| Jun 30, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 1,500 | $110.54 | $165,809.55 | View Details Filing |
| Jun 30, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 4,110 | $114.19 | $469,310.62 | View Details Filing |
| Jun 30, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 1,700 | $111.57 | $189,664.07 | View Details Filing |
| Jun 30, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 1,100 | $112.79 | $124,066.91 | View Details Filing |
| Jun 30, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 7,971 | $115.82 | $923,178.10 | View Details Filing |
| Jun 30, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 51,375 | $114.77 | $5,896,288.20 | View Details Filing |
| Jun 30, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 3,200 | $117.70 | $376,649.28 | View Details Filing |